Founded in 1993
  Year: 2003 | Volume: 11 | Issue: 3 | Pages: 161-163
  Review Article
  THE ROLE OF CHEMOTHERAPY IN THE MANAGEMENT OF RESECTABLE COLORECTAL CANCER
Davorin RADOSAVLJEVIC, Zorica TOMASEVIC, Ivan POPOV, Svetislav JELIC
  DOI:
  Abstract:
  Adjuvant chemotherapy has been established as the standard of care for patients with node-positive resected colon cancer. 5-fluorouracil modulated with leucovorin given for six months is currently the most widely accepted "standard" regimen. The role of adjuvant chemotherapy in stage II remain investigational and some prognostic indicators that correlate with higher risk for subsequent recurrence may be used for these patients when consider adjuvant chemotherapy. Other investigational approaches include regional, portal vein infusion and intraperitoneal therapy, immunotherapy, and new drugs, with proven activity in metastatic disease. Patients older than 70 years are also candidate for adjuvant therapy of colorectal cancer. Adjuvant chemotherapy of rectal cancer is often associated with radiotherapy and enhances local control seen with radiotherapy and improves survival of these patients.
  Key words: Colorectal Neoplasms; Carcinoma; Combined Modality Therapy; Surgery; Chemotherapy, Adjuvant; Antineoplastic Combined Chemotherapy Protocols
  Read full text in PDF [Full Text]
Next article

Previous article

Table of contents

Browse all Volumes

Search all Volumes
By keywords
By authors

  Search AoO for:
 

  Related articles in AoO:
 
About Journal | Editorial Board | Editorial Policy | Instructions for Authors | Open Access | Advertising | Payed issues | Article Submission Charge | Contact
Founder, owner and publisher: Oncology Institute of Vojvodina, Serbia
Online since 1997 (Abstracts only); 2000 (Abstracts and Full text)
ISSN: 0354-7310 eISSN: 1450-9520